Another promising target in the metabolic landscape of HNSCC is interleukin 4-induced gene 1 (IL4I1), an amino acid-catabolizing enzyme, that is mainly secreted in the synaptic cleft and expressed by antigen-presenting cells ([3]). Here, IL4I1 is linked to head and neck squamous cell carcinoma.